Point of Care Ultrasound as a Triage Tool in Novel Coronavirus. Is It Necessary or Not? by Hossein-nejad, Hooman
ADVANCED JOURNAL OF EMERGENCY MEDICINE. 2020;4(2s):e38 Hossein-nejad 
   
 
1 Copyright © 2020 Tehran University of Medical Sciences  
This open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 License (CC BY-NC 4.0). 
 
Editorial DOI: 10.22114/ajem.v4i2s.457 
Point of Care Ultrasound as a Triage Tool in Novel Coronavirus. Is It 




Department of Emergency Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. 
 
Email: hoseinnejad@tums.ac.ir 
Published online: 2020-05-28 
 
Overcrowding during pandemics, such as COVID-
19 necessitates the separation of respiratory 
patients in different locations with special 
protective measures. Thus, we allocated space to 
such a purpose and named it "respiratory 
emergency” in our emergency department and 
started to triage the patients coming in with 
respiratory tract signs and symptoms apart from 
others. However, the most critical point for the 
triage of respiratory patients is differentiation 
between COVID-19 and non COVID-19 suspicious 
patients as well as decision-making in terms of self- 
quarantine and outpatient treatment or admission. 
Considering the lack of test kits and more 
importantly, the uncertainty revolving around the 
performance and efficacy of tests, we used 
computed tomography (CT) scan as a triage tool, 
yet our machines cannot scan all these patients 
because we had up to more than eight hundred 
patients per day. Meanwhile three of us - 
emergency attending physicians - were under the 
impression that lung ultrasound may help.  
Therefore, we started to use lung ultrasound in a 
limited fashion. Fortunately, typical cases had 
peripheral and sub-pleural lesions that could be 
seen by ultrasound. Parallel to these efforts, limited 
reports were published about the use of ultrasound 
for COVID-19 in other regions. 
Evidently, a screen test is expected to have high 
sensitivity rather than specificity and the 
ultrasound provides this opportunity. Also we 
know the findings are not specific and for example 
we had observed these patterns in other viral 
epidemics, such as severe acute respiratory 
syndrome (SARS) or middle East Respiratory 
Syndrome (MERS). To date, several triage systems 
have been developed. The Italian version used by 
Dr. Volpicelli first and developed further by others, 
like that of Liam Devonport can exemplify this case 
(1, 2).  
Furthermore, a simple triage system has been 
developed by Dr. Mike Stone, based on the 
ultrasound of lungs plus oxygen need (3). This 
flowchart summarizes Dr. Stone’s idea with three 
elements for decision-making consisting of:  a) O2 
requirement, b) B lines and c) consolidation.  Three 
categories are enrolled. All patients with cough, 
fever and dyspnea or patients coming in from high-
risk areas or those having close contact with covid-
19 patients are enrolled. After bedsides sampling 
for polymerase chain reaction (PCR) test, the O2 
saturation is measured and lung ultrasound is also 
done and then according to the data obtained, four 
categories are created as follows: 
 Inpatients for whom supplementary O2 is not 
required. If lung ultrasound shows A profile, 
patients can be discharged to home quarantine. 
If lung shows profile B, patients should undergo 
quarantine plus follow-up. This quarantine can 
be at home or institutes considering the facilities 
available. 
 Patients, depending on supplementary oxygen, 
should be admitted according to the findings of 
lung ultrasound. If they have only B lines, they 
are admitted in the ward but if they have profile 
B plus consolidation, we should consider 
intensive care unit (ICU) beds for them. 
In essence, all these systems use lung ultrasound 
for decision-making, which is efficient in a majority 
of occasions, yet we have critically ill patients with 
dyspnea and decreased O2 saturation without 
proportionate changes in lungs even according to 
CT scanning. Thus, we could not justify their health 
status based on the findings of the imaging of 
respiratory system. 
To discover the cause of dyspnea in these patients, 
we included heart ultrasound in addition to lung 
ultrasound and witnessed a decline in ejection 
fraction and global hypokinesia, which can justify 
their unsatisfying health status. In the meantime, 
several case series about myocarditis in covid-19 
reveal the prevalence of myocarditis between 7% 
and 20% among patients (4). Increased troponin 
and change of the electrocardiogram (ECG) in these 
patients confirm myocarditis and help us to 
calibrate our care for the heart complaints sooner 
and more effectively. This approach might provide 
better prognosis for these patients.  
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Recommendation 
We suggest adding heart ultrasound to lung 
ultrasound in triaging the patients suspicious of 
COVID-19 or at least in the first doctor visit even if 
CT scan is available because myocarditis with 
pneumonia exists in some patients at the same 
time. Furthermore, we found that E-Point to Septal 
Separation (EPSS), as a reliable indicator of global 
hypokinesea in heart, can be used effectively 
instead of evaluating through eyeballing because 
eyeballing needs a high level of expertise and may 
be more operator-dependent and obtaining a four-
chamber view in supine critically ill patients is 
difficult when the operator lacks expertise. 
REFERENCES
1. Davenport L. First Protocol on How to Use Lung Ultrasound to Triage COVID-19. April 09, 2020. 
[Available from: https://www.medscape.com/viewarticle/928419]. 
2. Volpicelli G, Gargani L. Sonographic signs and patterns of COVID-19 pneumonia. Ultrasound 
J. 2020;12(1):22. 
3. Stone M. COVID-19 Lung Ultrasound Triage. [Available from:  https://assets.website-files.com/5a0cbe0 
8f1138d000147a9d4/5e7263c656e99f4b26c9a75b_2020-03_COVID_treatment.pdf]. 
4. BMJ Best Practice. Coronavirus disease 2019 (COVID-19). May 28, 2020 [Available from:  
https://bestpractice.bmj.com/topics/en-gb/3000168/pdf/3000168/Coronavirus%20disease%202019%2 
0%28COVID-19%29.pdf] 
